Skip Navigation Links
For Reflection Do not fear going forward slowly; fear only to stand still.
–Chinese Proverb

Pharmaceutical Resource Group

Biotechnology Consultants

The Pharmaceutical Resource Group (PRG) was founded in November, 1998 as an international consortium of experienced drug development consultants with a focus on Chemistry, Manufacturing, and Controls (CMC), preclinical, and clinical activities. Our work complies fully with the cGMP (current Good Manufacturing Practice) protocol.

PRG offers consulting and project management to small and emerging biotechnology companies to help guide them through the drug development process. We take clients through pre-clinical candidate selection, drug substance synthesis, drug product manufacturing, and the initiation of Phase I through III clinical trials. Additionally, we offer assistance with various QA activities, technical report development, and generation of documentation for regulatory support (with prior client review and modification), including IND, NDA, and various international filings. Documents can be completed in FDA Submission or Common Technical Doocument (CTD) formats. The PRG Team is highly experienced in technical due diligence activities for the acquisition or sale of clinical candidates or more advanced drug substances and products.

Our Team

Our international team of consultants live in the US (Philadelphia, Atlanta, San Diego, Seattle, and Washington, D.C.), Canada, France, Italy, Germany, and Japan. Most of our team members hold Ph.Ds in industry disciplines, and we average 25 years experience working in government and the private sector.

"Quality Solutions to Technical Issues"

Current News

US FDA Ahead Of Canada, Europe In Drug-Approval Race

      —  ♦  —

Expert Group Recommend That World Health Assembly ...

      —  ♦  —

The New Pharmacovigilance Legislation Will Impact US ...

      —  ♦  —

PETA Grant Enables Scientists To Guide Chinese ...

      —  ♦  —

Identifying Drugs That Could Help Fight Broad Range Of ...

      —  ♦  —